300584 海辰药业
午间休市 08-14 11:30:00
资讯
新帖
简况
海辰药业(300584)7月31日股东户数2.04万户，较上期减少4.4%
证券之星 · 08-05
海辰药业(300584)7月31日股东户数2.04万户，较上期减少4.4%
海辰药业：截至7月31日收盘，公司股东户数为20425户
证券之星 · 08-05
海辰药业：截至7月31日收盘，公司股东户数为20425户
海辰药业(300584)7月10日股东户数2.14万户，较上期减少2.5%
证券之星 · 07-23
海辰药业(300584)7月10日股东户数2.14万户，较上期减少2.5%
海辰药业：截至7月10日收盘，公司股东户数为21366户
证券之星 · 07-23
海辰药业：截至7月10日收盘，公司股东户数为21366户
7月17日海辰药业跌11.67%，博时战略新材料主题混合A基金重仓该股
证券之星 · 07-17
7月17日海辰药业跌11.67%，博时战略新材料主题混合A基金重仓该股
7月13日海辰药业跌6.07%，博时战略新材料主题混合A基金重仓该股
证券之星 · 07-13
7月13日海辰药业跌6.07%，博时战略新材料主题混合A基金重仓该股
股市必读：海辰药业（300584）7月3日董秘有最新回复
证券之星 · 07-06
股市必读：海辰药业（300584）7月3日董秘有最新回复
海辰药业：截至6月30日收盘，公司股东户数为21913户
证券之星 · 07-03
海辰药业：截至6月30日收盘，公司股东户数为21913户
6月29日海辰药业涨7.65%，博时战略新材料主题混合A基金重仓该股
证券之星 · 06-29
6月29日海辰药业涨7.65%，博时战略新材料主题混合A基金重仓该股
6月26日海辰药业跌8.59%，博时战略新材料主题混合A基金重仓该股
证券之星 · 06-26
6月26日海辰药业跌8.59%，博时战略新材料主题混合A基金重仓该股
股市必读：海辰药业(300584)股东户数2.1万户，较上期增加13.96%
证券之星 · 06-26
股市必读：海辰药业(300584)股东户数2.1万户，较上期增加13.96%
海辰药业：截至6月18日收盘，公司股东户数为20969户
证券之星 · 06-25
海辰药业：截至6月18日收盘，公司股东户数为20969户
海辰药业(300584.SZ)：注射用醋酸西曲瑞克获得药品注册批件
智通财经 · 06-23
海辰药业(300584.SZ)：注射用醋酸西曲瑞克获得药品注册批件
每周股票复盘：海辰药业（300584）股东户数减少10.14%，户均持股上升
证券之星 · 06-21
每周股票复盘：海辰药业（300584）股东户数减少10.14%，户均持股上升
6月18日海辰药业涨7.27%，博时战略新材料主题混合A基金重仓该股
证券之星 · 06-18
6月18日海辰药业涨7.27%，博时战略新材料主题混合A基金重仓该股
6月17日海辰药业（300584）涨停分析：医药高增、锂电落地驱动
证券之星 · 06-17
6月17日海辰药业（300584）涨停分析：医药高增、锂电落地驱动
股市必读：海辰药业(300584)股东户数1.84万户，较上期减少10.14%
证券之星 · 06-17
股市必读：海辰药业(300584)股东户数1.84万户，较上期减少10.14%
海辰药业（300584）披露2025年度权益分派实施公告，6月16日股价上涨1.11%
证券之星 · 06-16
海辰药业（300584）披露2025年度权益分派实施公告，6月16日股价上涨1.11%
海辰药业：截至6月10日收盘，公司股东户数为18401户
证券之星 · 06-16
海辰药业：截至6月10日收盘，公司股东户数为18401户
海辰药业(300584.SZ)：注射用盐酸头孢甲肟通过仿制药一致性评价
智通财经 · 06-05
海辰药业(300584.SZ)：注射用盐酸头孢甲肟通过仿制药一致性评价
公司概况
公司名称：
南京海辰药业股份有限公司
所属行业：
医药制造业
上市日期：
2017-01-12
主营业务：
南京海辰药业股份有限公司的主营业务是化学制剂、原料药及中间体的研发、生产、销售，同时拓展锂电材料业务。公司的主要产品是抗生素类、抗病毒类、利尿类、消化类、免疫调节类、心脑血管类、原料药及中间体、锂电池电解液添加剂。
发行价格：
11.11
{"stockData":{"symbol":"300584","market":"SZ","secType":"STK","nameCN":"海辰药业","latestPrice":34.9,"timestamp":1786678350000,"preClose":35.14,"halted":0,"volume":3741700,"delay":0,"changeRate":-0.0068,"floatShares":82131500,"shares":120000000,"eps":0.3699,"marketStatus":"午间休市","change":-0.24,"latestTime":"08-14 11:30:00","open":34.88,"high":36.55,"low":34.37,"amount":132000000,"amplitude":0.062,"askPrice":34.9,"askSize":14,"bidPrice":34.89,"bidSize":1,"shortable":0,"etf":0,"ttmEps":0.3699,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1786683600000},"marketStatusCode":3,"adr":0,"adjPreClose":35.14,"symbolType":"stock","openAndCloseTimeList":[[1786671000000,1786678200000],[1786683600000,1786690800000]],"highLimit":38.65,"lowLimit":31.63,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":120000000,"isCdr":false,"pbRate":3.94,"roa":"--","peRate":94.349824,"roe":"1.64%","epsLYR":0.3505,"committee":0.287879,"marketValue":4188000000,"turnoverRate":0.0456,"status":1,"floatMarketCap":2866000000},"requestUrl":"/m/hq/s/300584/wiki","defaultTab":"wiki","newsList":[{"id":"2657451089","title":"海辰药业(300584)7月31日股东户数2.04万户，较上期减少4.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657451089","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657451089?lang=zh_cn&edition=full","pubTime":"2026-08-05 17:45","pubTimestamp":1785923155,"startTime":"0","endTime":"0","summary":"证券之星消息，近日海辰药业披露，截至2026年7月31日公司股东户数为2.04万户，较7月10日减少941.0户，减幅为4.4%。在化学制药行业个股中，海辰药业股东户数低于行业平均水平，截至7月31日，化学制药行业平均股东户数为3.59万户。从股价来看，2026年7月10日至2026年7月31日，海辰药业区间跌幅为8.05%，在此期间股东户数减少941.0户，减幅为4.4%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500032523.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657594162","title":"海辰药业：截至7月31日收盘，公司股东户数为20425户","url":"https://stock-news.laohu8.com/highlight/detail?id=2657594162","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657594162?lang=zh_cn&edition=full","pubTime":"2026-08-05 11:37","pubTimestamp":1785901027,"startTime":"0","endTime":"0","summary":"证券之星消息，海辰药业(300584)08月05日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止到7月31日公司股东人数是多少？谢谢海辰药业回复：尊敬的投资者您好，截至7月31日收盘，公司股东户数为20425户，感谢对海辰药业的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500017940.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653451017","title":"海辰药业(300584)7月10日股东户数2.14万户，较上期减少2.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653451017","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653451017?lang=zh_cn&edition=full","pubTime":"2026-07-23 17:56","pubTimestamp":1784800584,"startTime":"0","endTime":"0","summary":"证券之星消息，近日海辰药业披露，截至2026年7月10日公司股东户数为2.14万户，较6月30日减少547.0户，减幅为2.5%。在化学制药行业个股中，海辰药业股东户数低于行业平均水平，截至7月10日，化学制药行业平均股东户数为3.58万户。从股价来看，2026年6月30日至2026年7月10日，海辰药业区间跌幅为5.02%，在此期间股东户数减少547.0户，减幅为2.5%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072300036851.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653713663","title":"海辰药业：截至7月10日收盘，公司股东户数为21366户","url":"https://stock-news.laohu8.com/highlight/detail?id=2653713663","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653713663?lang=zh_cn&edition=full","pubTime":"2026-07-23 11:42","pubTimestamp":1784778136,"startTime":"0","endTime":"0","summary":"证券之星消息，海辰药业(300584)07月22日在投资者关系平台上答复投资者关心的问题。投资者提问：你好，请问截至7月10日股东人数是多少？谢谢海辰药业回复：尊敬的投资者您好，截至7月10日收盘，公司股东户数为21366户，感谢对海辰药业的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072300019833.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652406225","title":"7月17日海辰药业跌11.67%，博时战略新材料主题混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2652406225","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652406225?lang=zh_cn&edition=full","pubTime":"2026-07-17 16:54","pubTimestamp":1784278452,"startTime":"0","endTime":"0","summary":"证券之星消息，7月17日海辰药业跌11.67%，收盘报31.34元，换手率9.02%，成交量7.4万手，成交额2.42亿元。重仓海辰药业的公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为博时基金的博时战略新材料主题混合A。博时战略新材料主题混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700030678.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584","159703"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651796192","title":"7月13日海辰药业跌6.07%，博时战略新材料主题混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2651796192","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651796192?lang=zh_cn&edition=full","pubTime":"2026-07-13 16:54","pubTimestamp":1783932896,"startTime":"0","endTime":"0","summary":"证券之星消息，7月13日海辰药业跌6.07%，收盘报32.32元，换手率4.48%，成交量3.68万手，成交额1.21亿元。重仓海辰药业的公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为博时基金的博时战略新材料主题混合A。博时战略新材料主题混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071300023927.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584","159703"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649199966","title":"股市必读：海辰药业（300584）7月3日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2649199966","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649199966?lang=zh_cn&edition=full","pubTime":"2026-07-06 04:06","pubTimestamp":1783281976,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘，海辰药业报收于37.9元，上涨0.05%，换手率6.82%，成交量5.6万手，成交额2.12亿元。董秘最新回复投资者： 请问贵公司截止到六月三十号股东人数是多少啊？谢谢董秘： 尊敬的投资者您好，截至6月30日收盘，公司股东户数为21913户，感谢对海辰药业的关注！交易信息汇总资金流向7月3日主力资金净流入159.4万元，占总成交额0.0%；游资资金净流入143.79万元，占总成交额0.0%；散户资金净流出303.19万元，占总成交额0.0%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070600001424.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648657330","title":"海辰药业：截至6月30日收盘，公司股东户数为21913户","url":"https://stock-news.laohu8.com/highlight/detail?id=2648657330","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648657330?lang=zh_cn&edition=full","pubTime":"2026-07-03 17:00","pubTimestamp":1783069256,"startTime":"0","endTime":"0","summary":"证券之星消息，海辰药业(300584)07月03日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵公司截止到六月三十号股东人数是多少啊？谢谢海辰药业回复：尊敬的投资者您好，截至6月30日收盘，公司股东户数为21913户，感谢对海辰药业的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070300030752.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647322904","title":"6月29日海辰药业涨7.65%，博时战略新材料主题混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2647322904","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647322904?lang=zh_cn&edition=full","pubTime":"2026-06-29 16:51","pubTimestamp":1782723109,"startTime":"0","endTime":"0","summary":"证券之星消息，6月29日海辰药业涨7.65%，收盘报37.71元，换手率12.56%，成交量10.32万手，成交额3.84亿元。重仓海辰药业的公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为博时基金的博时战略新材料主题混合A。博时战略新材料主题混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900024854.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","159703","300584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646358662","title":"6月26日海辰药业跌8.59%，博时战略新材料主题混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2646358662","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646358662?lang=zh_cn&edition=full","pubTime":"2026-06-26 16:58","pubTimestamp":1782464307,"startTime":"0","endTime":"0","summary":"证券之星消息，6月26日海辰药业跌8.59%，收盘报35.03元，换手率10.21%，成交量8.39万手，成交额3.03亿元。重仓海辰药业的公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为博时基金的博时战略新材料主题混合A。博时战略新材料主题混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600030799.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","159703","300584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646071908","title":"股市必读：海辰药业(300584)股东户数2.1万户，较上期增加13.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646071908","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646071908?lang=zh_cn&edition=full","pubTime":"2026-06-26 01:10","pubTimestamp":1782407418,"startTime":"0","endTime":"0","summary":"截至2026年6月25日收盘，海辰药业报收于38.32元，下跌4.49%，换手率11.99%，成交量9.85万手，成交额3.77亿元。股本股东变化：截至2026年6月18日，海辰药业股东户数为2.1万户，较6月10日增加2568.0户，增幅13.96%。交易信息汇总资金流向6月25日主力资金净流出4124.01万元，占总成交额0.0%；游资资金净流入99.35万元；散户资金净流入4024.66万元，占总成交额0.0%。户均持股数量由上期的6521.0股减少至5723.0股，户均持股市值为23.46万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600000729.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646820143","title":"海辰药业：截至6月18日收盘，公司股东户数为20969户","url":"https://stock-news.laohu8.com/highlight/detail?id=2646820143","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646820143?lang=zh_cn&edition=full","pubTime":"2026-06-25 15:39","pubTimestamp":1782373149,"startTime":"0","endTime":"0","summary":"证券之星消息，海辰药业(300584)06月25日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司6月20日最新股东人数是多少？谢谢海辰药业回复：尊敬的投资者您好，截至6月18日收盘，公司股东户数为20969户，感谢关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062500023189.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645886297","title":"海辰药业(300584.SZ)：注射用醋酸西曲瑞克获得药品注册批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2645886297","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645886297?lang=zh_cn&edition=full","pubTime":"2026-06-23 15:53","pubTimestamp":1782201212,"startTime":"0","endTime":"0","summary":"智通财经APP讯，海辰药业(300584.SZ)发布公告，公司于近日收到国家药品监督管理局核准签发的注射用醋酸西曲瑞克《药品注册证书》。注射用醋酸西曲瑞克是第三代促性腺激素释放激素(GnRH)拮抗剂，适应症为：辅助生育技术中，对控制性卵巢刺激的患者，本品可防止提前排卵。注射用醋酸西曲瑞克具有起效快速，卵巢过度刺激综合征(OHSS)、不良事件发生率低的优势。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1457443.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300584","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645953510","title":"每周股票复盘：海辰药业（300584）股东户数减少10.14%，户均持股上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2645953510","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645953510?lang=zh_cn&edition=full","pubTime":"2026-06-21 01:29","pubTimestamp":1781976549,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘，海辰药业报收于41.0元，较上周的31.16元上涨31.58%。本周，海辰药业6月18日盘中最高价报42.97元。公司公告汇总2025年度权益分派实施公告南京海辰药业股份有限公司2025年度权益分派方案已获2026年5月27日召开的2025年度股东会审议通过。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062100000225.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644064867","title":"6月18日海辰药业涨7.27%，博时战略新材料主题混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2644064867","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2644064867?lang=zh_cn&edition=full","pubTime":"2026-06-18 16:45","pubTimestamp":1781772303,"startTime":"0","endTime":"0","summary":"证券之星消息，6月18日海辰药业涨7.27%，收盘报41.0元，换手率22.73%，成交量18.66万手，成交额7.57亿元。重仓海辰药业的公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为博时基金的博时战略新材料主题混合A。博时战略新材料主题混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061800028988.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","159703","300584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644271604","title":"6月17日海辰药业（300584）涨停分析：医药高增、锂电落地驱动","url":"https://stock-news.laohu8.com/highlight/detail?id=2644271604","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2644271604?lang=zh_cn&edition=full","pubTime":"2026-06-17 15:38","pubTimestamp":1781681902,"startTime":"0","endTime":"0","summary":"证券之星消息，海辰药业6月17日涨停收盘，收盘价38.22元。该股于13点29分涨停，未打开涨停，截止收盘封单资金为5234.65万元，占其流通市值1.67%。6月17日的资金流向数据方面，主力资金净流入1.13亿元，占总成交额25.51%，游资资金净流出798.44万元，占总成交额1.81%，散户资金净流出1.05亿元，占总成交额23.7%。近5日资金流向一览见下表：该股为固态电池，锂电池，新能源汽车概念热股，当日固态电池概念上涨0.88%，锂电池概念上涨0.04%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061700021164.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1515","300584","159938","BK1161","BK0239","09939","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644661760","title":"股市必读：海辰药业(300584)股东户数1.84万户，较上期减少10.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2644661760","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2644661760?lang=zh_cn&edition=full","pubTime":"2026-06-17 04:23","pubTimestamp":1781641390,"startTime":"0","endTime":"0","summary":"截至2026年6月16日收盘，海辰药业报收于31.85元，上涨1.11%，换手率3.11%，成交量2.55万手，成交额8109.61万元。股本股东变化：截至2026年6月10日股东户数为1.84万户，较4月30日减少10.14%，户均持股增至6521.0股。公司公告汇总2025年度权益分派实施公告南京海辰药业股份有限公司2025年度权益分派方案已获2026年5月27日召开的2025年度股东会审议通过。董秘： 尊敬的投资者您好，截至6月10日收盘，公司股东户数为18401户，感谢关注！","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061700003721.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643575936","title":"海辰药业（300584）披露2025年度权益分派实施公告，6月16日股价上涨1.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2643575936","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2643575936?lang=zh_cn&edition=full","pubTime":"2026-06-16 18:42","pubTimestamp":1781606537,"startTime":"0","endTime":"0","summary":"截至2026年6月16日收盘，海辰药业报收于31.85元，较前一交易日上涨1.11%，最新总市值为38.22亿元。该股当日开盘31.51元，最高32.58元，最低31.14元，成交额达8109.61万元，换手率为3.11%。公司于2026年6月16日披露《2025年度权益分派实施公告》。公告显示，南京海辰药业股份有限公司2025年度权益分派方案已获2026年5月27日召开的2025年度股东会审议通过。本次实施的分配方案与股东会审议通过的一致，且在规定时限内实施。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061600036494.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643422737","title":"海辰药业：截至6月10日收盘，公司股东户数为18401户","url":"https://stock-news.laohu8.com/highlight/detail?id=2643422737","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2643422737?lang=zh_cn&edition=full","pubTime":"2026-06-16 16:36","pubTimestamp":1781598967,"startTime":"0","endTime":"0","summary":"证券之星消息，海辰药业(300584)06月16日在投资者关系平台上答复投资者关心的问题。投资者提问：你好董秘，截止2026年6月10日股东人数多少？谢谢！海辰药业回复：尊敬的投资者您好，截至6月10日收盘，公司股东户数为18401户，感谢关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061600028943.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641180113","title":"海辰药业(300584.SZ)：注射用盐酸头孢甲肟通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2641180113","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2641180113?lang=zh_cn&edition=full","pubTime":"2026-06-05 15:54","pubTimestamp":1780646071,"startTime":"0","endTime":"0","summary":"智通财经APP讯，海辰药业(300584.SZ)发布公告，公司于近日收到国家药品监督管理局核准签发的《药品补充申请批准通知书》，该产品通过仿制药质量和疗效一致性评价。注射用盐酸头孢甲肟是第三代头孢菌素类药物，通过抑制细胞壁的生物合成而产生杀菌作用，对革兰阴性菌、阳性菌均有良好的抗菌作用，是一种临床应用广泛的广谱抗生素，具有广谱、耐酶、高效、安全的特性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1450662.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"海辰药业(300584.SZ)：注射用盐酸头孢甲肟通过仿制药一致性评价","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","300584"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1786678411739,"stockEarnings":[{"period":"1week","weight":0.0591},{"period":"1month","weight":0.0403},{"period":"3month","weight":-0.0871},{"period":"6month","weight":-0.1922},{"period":"1year","weight":-0.2913},{"period":"ytd","weight":-0.2985}],"compareEarnings":[{"period":"1week","weight":0.0068},{"period":"1month","weight":-0.0101},{"period":"3month","weight":-0.0504},{"period":"6month","weight":-0.038},{"period":"1year","weight":0.0661},{"period":"ytd","weight":-0.0106}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"南京海辰药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"20425人(较上一季度减少4.40%)","perCapita":"4021股","listingDate":"2017-01-12","address":"江苏省南京市栖霞区经济技术开发区恒发路1号","registeredCapital":"12000万元","survey":" 南京海辰药业股份有限公司的主营业务是化学制剂、原料药及中间体的研发、生产、销售，同时拓展锂电材料业务。公司的主要产品是抗生素类、抗病毒类、利尿类、消化类、免疫调节类、心脑血管类、原料药及中间体、锂电池电解液添加剂。","listedPrice":11.11},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海辰药业(300584)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海辰药业(300584)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海辰药业,300584,海辰药业股票,海辰药业股票老虎,海辰药业股票老虎国际,海辰药业行情,海辰药业股票行情,海辰药业股价,海辰药业股市,海辰药业股票价格,海辰药业股票交易,海辰药业股票购买,海辰药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海辰药业(300584)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海辰药业(300584)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}